Biohaven (BHVN) Exchange Rate Effect (2022 - 2026)
Biohaven (BHVN) posted Exchange Rate Effect of $16000.0 for Q1 2026, up 14.29% sequentially from $14000.0 in Q3 2025, and down 30.43% YoY from $23000.0 in Q1 2025.
Powered by 
Analysis
Biohaven (BHVN) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Biohaven has reported Exchange Rate Effect for 5 years, with the latest figure at $16000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 30.43% year-over-year to $16000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10000.0 (down 109.62% YoY) and the FY2025 annual result came in at -$3000.0, down 104.0% from the prior year.
- Exchange Rate Effect improved to $16000.0 in Q1 2026 per BHVN's latest filing, from $14000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $429000.0 in Q4 2022 and troughed at -$310000.0 in Q4 2023.
- A 5-year average of $1666.7 and a median of $4000.0 in 2024 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 483.33% in 2025, down 471.43% in 2025.
- Over 5 years, Exchange Rate Effect stood at $429000.0 in 2022, then tumbled by 172.26% to -$310000.0 in 2023, then surged by 128.39% to $88000.0 in 2024, then tumbled by 84.09% to $14000.0 in 2025, then increased by 14.29% to $16000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $16000.0, $14000.0, and -$40000.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Biohaven | 2.37 Bn | 2.10 Bn | - | 3,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,000.00 |
| Mar 31, 2026 | 16,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Jun 30, 2025 | -40,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Dec 31, 2024 | 88,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Mar 31, 2024 | -6,000.00 |
| Dec 31, 2023 | -310,000.00 |
| Sep 30, 2023 | -40,000.00 |
| Jun 30, 2023 | -162,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Dec 31, 2022 | 429,000.00 |